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Primary infection by Plasmodium falciparum or P. vivax
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The clinical and parasitological characteristics of the rst naturally acquired malarial infection have rarely been
documented in humans. When 243 migrants from non-endemic Java were followed from the day of their arrival
in Indonesian Papua, 217 (89%) were found to become infected with Plasmodium falciparum and/or P. vivax
before they were lost to follow-up. The incidence of malarial infection in the children investigated (who were
aged 6–10 years) was indistinguishable from that in the adults (aged >20 years), with 1.10 and 1.14 P. falciparum
infections/person-year (relative risk=0.97; 95% condence interval=0.72–1.29) and 1.47 and 1.49 P. vivax
infections/person-year (relative risk= 0.99; 95% condence interval= 0.72–1.29), respectively. During their
rst infections, the children had higher P. falciparum parasitaemias than the adults (with geometric means of 1318
and 759 parasites/ml, respectively; P=0.04) but similar P. vivax parasitaemias (with geometric means of 355 and
331 parasites/ml, respectively; P=0.76). At rst infection, 56% of the subjects were febrile and 90% complained
of symptoms. There were no diVerences between children and adults with respect to these two parameters, either
for P. falciparum or P. vivax. These ndings indicate that, with promptly diagnosed and treated uncomplicated
malaria, migrant children and adults in north–eastern Indonesian Papua have an equal risk of malarial infection
and of disease following their rst infections with P. falciparum and P. vivax.

The results of therapeutic or experimental
challenge of adult volunteers constitute most
of the detailed body of clinical knowledge
of acute malaria in non-immune people.
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Malaria therapy early in the 20th century
cured many thousands of neurosyphilis cases
and studies of these infections profoundly
improved our understanding of the clinical
aspects of malaria (Von Juaregg, 1922).
During World War II, the strategic urgency
for new antimalarial drugs prompted clinical
studies in soldiers and prison inmates (Collins
and JeVery, 1999). In more recent years, the
results of a few experimental challenges have
provided much more detailed information on
the blood-chemistry, cell-prole and immunological aspects of malaria (Herrington et al.,
1991; Church et al., 1997; HoVman et al.,
2002). These studies have, however, shed
no light on malarial infection and disease in
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children. In experimental challenge, moreover, it is diYcult to mimic the eVects
of treatment-seeking behaviour or natural
challenge by wild strains of the parasite.
Although epidemics of the disease may
oVer opportunities for investigating primary
malaria in human populations, there appear
to have been no detailed clinical and parasitological observations published on primary
infection during malaria epidemics.
The organized relocation of families from
Java to Indonesian Papua (formerly known
as Irian Jaya), at various times between
1965 and 1997, resulted in non-immune
people of all ages being abruptly exposed
to hyper- and holo-endemic malaria. An
aggressive DDT-spraying campaign in the
1950s eradicated endemic malaria from East
and West Java (Atmosoedjono, 1990; Arbani,
1992) and left only a few scattered foci of
hypo-endemic risk in Central Java (Baird
et al., 1996). The unpublished records of
the Indonesian Ministry of Health show
that, between 1969 and 1996, the mean
annual incidence of malaria throughout Java
and Bali was only 0.03 case/1000 residents.
Thus, the migrants investigated in the present study (with a mean age of 25 years of
age and screened against residence on other
islands or in a known focus of malaria risk
on Java) arrived in Indonesian Papua having
an estimated individual risk of just 0.075%
for a single prior episode of malaria. In
north–eastern Papua, in contrast, the risk
of malarial infection within 3–6 months is
100% ( Jones et al., 1994; FryauV et al.,
1995; Ohrt et al., 1997; Taylor et al., 1999;
Baird et al., 2001).
In a retrospective study of one transmigration community in Indonesian Papua, a
high risk of evacuation with severe, Plasmodium
falciparum malaria during the rst 6 months
was documented (Baird et al., 1998). The
risk of evacuation was markedly higher for
the adult migrants than for their children
[relative risk=2.7; 95% condence interval
(CI)= 1.9–3.8], even though the risk of
infection with P. falciparum appeared similar
for all age-groups (Baird et al., 1991, 1995).

Observations on travellers with malaria, on the
infections occurring during malaria epidemics,
and during a retrospective investigation of
another transmigration settlement also indicated that malaria-naṏve adults are at higher
risk of severe disease than malaria-naṏve
children (Gill, 1936; Bastien, 1987; Greenberg
and Lobel, 1990; Buck and Eichenlaub, 1994;
Some, 1994; Baird et al., 2003). It seems
possible that intrinsic age-related diVerences
in the immune response to primary infection
form the basis of this adult susceptibility to
severe disease. In the present study, to explore
this possibility, the rst smear-conrmed
P. falciparum or P. vivax infections suVered
by malaria-naṏve Javanese transmigrants to
Indonesian Papua, and the disease associated
with each of these primary infections, were
investigated.

SUBJECTS AND METHODS
Study Site
The study site was the transmigration village
known as Satuan Permukiman (Settlement
Unit) 2 (SP2), which lies, near the Pacic
Ocean, in north–eastern Papua, Indonesia.
The village, which has already been described
in detail by Krisin et al. (2003), covers an
area of about 4 km2. It had 1428 residents in
1996, most (78.3%) of whom were migrants
from Java. The Indonesian Department of
Transmigration constructed SP2 in 1995
and 1996. The housing, of uniform woodplank and tin-roof construction, presented
few obstacles to host-seeking mosquitoes.
Hyper- to holo-endemic malaria, transmitted
by the Anopheles punctulatus complex of
mosquitoes, occurs throughout most of north–
eastern Papua. Almost all of the malaria is
caused by P. falciparum or P. vivax, with only
occasional infections by P. malariae and very
rare infections by P. ovale (Baird et al., 1990,
1991). In compliance with the regulations
of the Department of Transmigration, newcomers to SP2 received weekly chloroquine
(5 mg/kg) for 12 weeks, as chemoprophylaxis.
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Compliance with this regimen was supervised
among the study subjects, to ensure uniform
usage of chloroquine across the cohort. The
results of previous studies in similar settings
indicated, however, that chloroquine was no
more eVective than placebo in preventing
infection by P. falciparum or P. vivax (Baird
et al., 1995; FryauV et al., 1995).

Follow-up
A research station and clinic were established
in SP2 in July 1996, to enable a longitudinal
study of adults (aged >20 years) and children
(aged 6–12 years) who had migrated from
non-malarious areas of Java. The study
protocol was reviewed and approved by
the relevant American and Indonesian committees for the protection of human subjects, and informed consent was obtained in
accordance with the United States Navy’s
regulations governing the use of human subjects in medical research (SECNAVINST
3900.39B). A detailed description of the
subjects and the methods of follow-up is
available elsewhere (Krisin et al., 2003). In
brief, 243 subjects were enrolled on their day
of arrival at SP2 (between 25 August and
3 October 1996) and within 48 h of their
arrival in Indonesian Papua. This cohort was
followed for 33 months. The regimen of
follow-up included physical and laboratory
examinations on enrolment and the production of routine bloodsmears and the
recording of axillary temperatures every
2 weeks (or whenever the subject complained
of symptoms consistent with malaria). A
member of the research team visited each
subject in his or her home every other day,
to ascertain the subject’s health status by
a standardized procedure. The intention
was to detect all episodes of clinical illness.
Technicians certied as expert in the diagnosis
of malaria by microscopical examination of
Giemsa-stained thick bloodsmears provided
diagnostic services. A thick smear was only
considered negative if a technician checking
200 elds at a magnication of ×1000 failed
to detect a single malarial parasite.
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The analysis here is limited to each subject’s rst infection with P. falciparum and his
or her rst infection with P. vivax. Subjects
parasitaemic rst with P. falciparum were
treated and still considered at risk for P. vivax,
and vice versa. Owing to the lingering suppression of parasitaemia by the administered
therapy, however, the 4 weeks following the
rst treatment for malarial infection were not
counted as time at risk of infection by the
other species. Individual subjects only ceased
contributing ‘person-time at risk’ after having
experienced infection by both P. falciparum
and P. vivax. Subjects found smear-positive
were given directly observed treatment with
either chloroquine (25 mg/kg, in three doses
over 48 h) or meoquine (25 mg/kg, as a single
dose) according to a randomized (1:1) assignment at enrolment. Non-pregnant subjects
positive for P. vivax also received primaquine
(30 mg daily for 14 days).

Classication of Infections
First infections were classied as febrile or
afebrile, a febrile case having a patent parasitaemia and a documented axillary temperature of >37.5°C. The rst parasitaemias
of 22 subjects were only detected when
the routine bloodsmears produced biweekly
were checked. The axillary temperature of a
subject from whom a routine blood sample
was being collected was not recorded if that
subject did not complain of illness at that
time. Any complaint of illness or notice of
fever would have prompted the subject’s
referral for medical attention, the production
and examination of a non-routine bloodsmear
and the recording of the subject’s axillary
temperature. Each subject found parasitaemic
only as the result of the examination of a
routine blood sample was therefore assumed
to have been afebrile and asymptomatic at
the time that sample had been collected.
First infections were also classied as
symptomatic or asymptomatic, on the basis
of parasitaemia concurrent with a subject
seeking medical attention or complaining of
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symptoms consistent with malaria (i.e. fever,
chills, headache, nausea, vomiting, myalgia,
malaise and/or diarrhoea) during a home
visit.

Statistical Analysis
Risk of infection was measured as both
the mean time (the mean number of days
from arrival ) to the rst slide-conrmed
parasitaemia and the incidence of infection.
Incidence was calculated as the number of
infections divided by the number of personyears at risk. The results were expressed
statistically as means or frequencies, and
generally analysed using unpaired Student’s
t-tests or Mantel–Haenszel tests. A x2 test
was used to assess diVerences in calculated
proportions. A P-value of å0.05 was considered indicative of statistical signicance.
Where appropriate, a relative risk (RR) or
odds ratio (OR) and its 95% condence
interval (CI) were calculated. Kaplan–Meier
survival analysis was used to calculate the
cumulative probability curves, in weeks to the
rst malarial infection. All the analyses were
carried out using version 8.0 of the SPSS
(SPSS Inc., Chicago, IL) or version 6.0 of
the Epi Info (Centers for Disease Control and
Prevention, Atlanta, GA) software packages.

RESULTS
Table 1 presents the demographic and parasitological data collected, stratied by the
two age-groups. The overall ratio of males
to females who participated in the study was
approximately 2:1 (163:80). Almost all of
the subjects — 93% (90/97) of the children
and 87% (127/146) of the adults (RR=1.07;
CI=0.98–1.16) — experienced at least
one malarial infection over the observation
period. Twenty-ve of the 26 subjects who
were never found parasitaemic were lost to
follow-up after deciding to return to Java;
the median times these 26 subjects were
followed were 11 (range=2–29) weeks for
the seven children and 20 (range=2–144)

weeks for the 19 adults. One adult subject
never developed parasitaemia during all 33
months of follow-up.
The Figure illustrates the cumulative risk
of infection by P. falciparum and P. vivax
among children and adults. The mean time
to rst parasitaemia was essentially identical
for P. falciparum (185 days, with a range
11–856 days) and P. vivax (190 days,
with a range 14–901 days; P=0.729). The
times to rst parasitaemia were essentially
the same for the children and adults, both
for P. falciparum ( P =0.57) and P. vivax
( P = 0.29). Likewise, the incidence of
infection was similar among the children
and adults, both for P. falciparum (1.10
infections/child-year v. 1.14 infections/
adult-year; RR=0.97; CI=0.72–1.29) and
for P. vivax (1.47 infections/child-year v.
1.49 infections/adult-year; RR=0.99; CI=
0.75–1.30). Children and adults were at
equal risk of infection with P. falciparum or
P. vivax. Children, however, had generally
higher rst P. falciparum parasitaemias than
the adults (with geometric mean counts of
1318 v. 759 parasites/ml; P =0.04), although
the levels of the rst P. vivax parasitaemias
were similar in the children and adults
investigated (with geometric mean counts
of 355 v. 331 parasites/ml; P = 0.76). In
both age-groups, the P. falciparum counts
were signicantly higher than the P. vivax
( P<0.001).
At rst infection with P. falciparum or
P. vivax, 56% of the subjects were febrile and
90% complained of malaria-like symptoms
(Table 1). With P. falciparum, there was no
signicant diVerence between the adults and
children in the risk of fever (OR =1.19; P=
0.60), or complaint of illness (OR=0.55;
P =0.20). With P. vivax, similarly, there was
no signicant diVerence between adults and
children in the frequency of associated fever
(OR=1.29; P =0.40) or complaint of illness (OR =0.77; P=0.59). Between the
two species, no diVerences appeared in the
likelihood of fever (OR=1.35; P =0.16) or
reported illness (OR =0.84; P =0.62).

CI, Condence interval.

incidence (infections/person-year)
Plasmodium falciparum
Plasmodium vivax
1.1
1.47

1.14
1.49

180 (21–901)
182 (18–856)

192 (14–515)
200 11–764)

mean time and (range) to first infection (days)
With P. falciparum
With P. vivax

12 (18/146)
44 (64/146)
30 (45/146)
49 (71/146)
34 (50/146)
58.0 (58/100)
91.7 (100/109)
49.5 (53/107)
91.7 (111/121)
755 (539–1059)
330 (250–438)

7 (7/97)
44 (43/97)
36 (35/97)
49 (47/97)
40 (39/97)
62.1 (41/66)
85.9 (67/78)
55.8 43/77)
89.6 (77/86)

% of subjects and (no. of subjects/no. investigated)
Lost to follow-up
Primary infection with P. falciparum
First P. falciparum infection after P. vivax
Primary infection with P. vivax
First P. vivax infection after P. falciparum
Febrile on rst P. falciparum infection
Complaining of illness on rst P. falciparum infection
Febrile on rst P. vivax infection
Complaining of illness on rst P. vivax infection

146
31.8 (20–58)
31
100:46

Adults

geometric mean level of parasitaemia and (95% CI) ( parasites/ml)
First P. falciparum infection
1348 (860–2114)
First P. vivax infection
354 (255–491)

97
9.2 (6–12)
9
63:34

Children

Summary of the demographic and parasitological data on the study cohort

No. of subjects enrolled
Mean age and (range) (years)
Median age (years)
No. of males:females

Variable

TABLE 1.

243
22.8 (6–58)
26
163:80

All subjects

0.55
1.02
1.27
0.99
1.29
1.19
0.55
1.29
0.77

(0.20–1.48)
(0.59–1.77)
(0.71–2.26)
(0.57–1.71)
(0.73–2.27)
(0.60–2.36)
(0.20–1.52)
(0.69–2.42)
(0.27–2.18)

Odds ratio and
(95% CI)

0.97 (0.72–1.29)
0.99 (0.75–1.30)

RR and
(95% CI)

0.57
0.29

0.41
0.76

P
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FIG. The weekly cumulative incidences of Plasmodium falciparum parasitaemia among adult (s ) and child
(d ) migrants from Java, and the corresponding data for P. vivax parasitaemia among the same adults (h ) and
children (j ), beginning on the day the migrants arrived at SP2 in Papua, Indonesia.

The clinical characteristics of the rst
infections with P. falciparum or P. vivax were
also compared on the basis of prior exposure
(in one or more infections) to the other
species of parasite. Of all the ‘rst’ infections
considered, 55% of those in children and
59% of those in adults represented primary
exposures to malaria. The remainder of the
‘rst’ infections had been preceded by at
least one infection with the other species
and were therefore considered secondary
exposures to malaria. The risk of fever
or complaint of illness appeared the same
for the primary and secondary exposures
(Tables 2 and 3). For P. falciparum preceded
by P. vivax, the OR for fever were 0.82
( P=0.71) in children and 0.60 ( P =0.25)
in adults, with corresponding OR for com-

plaint of illness of 0.66 ( P=0.54) and 1.15
( P=0.84), respectively. For P. vivax preceded by P. falciparum, the OR for fever
were 1.05 ( P =0.92) in children and 2.09
( P=0.06) in adults whereas those for complaint of illness were 4.92 ( P =0.07) in
children and 1.47 ( P=0.56) in adults.
DISCUSSION
The observations reported here demonstrate
the high risk of disease with rst exposure
to P. falciparum or P. vivax among Javanese
migrants to north–eastern Papua, Indonesia.
As their rst P. falciparum or P. vivax parasitaemias became patent, more than half of
the subjects were found febrile and >90%

PRIMARY MALARIA IN NON-IMMUNE MIGRANTS
TABLE 2.
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EVect of prior exposure to Plasmodium vivax upon risk of fever or illness with primary exposure to P. falciparum
Prior Plasmodium vivax (no. of subjects)?

Febrile
Afebrile
Complaint of illness
No complaint of illness

Yes

No

Odds ratio and (95% CI)

41
13
66
8

58
36
95
12

1.96 (0.87–4.44)
1.04 (0.37–2.98)

CI, Condence interval.

TABLE 3.

EVect of prior exposure to Plasmodium falciparum upon risk of fever or illness with primary exposure to P. vivax
Prior Plasmodium falciparum (no. of subjects)?

Febrile
Afebrile
Complaint of illness
No complaint of illness

Yes

No

Odds ratio and (95% CI)

39
45
77
12

57
43
111
7

0.65 (0.35–1.22)
0.40 (0.14–1.17)

CI, Condence interval.

complained of being ill. The cyclical nature
of fever caused by malarial parasites may
explain why the prevalence of fever (detected
at a single point in each infection) was lower
than the frequency of reported illness. The
possibility that the 12 weeks of chloroquine
prophylaxis given to new migrants caused
signicant confounding of the risks of fever
or complaint of illness was discounted,
because 336 of the 394 rst infections
investigated occurred after this prophylaxis
had ended. The slight lags in the development of the rst detected P. falciparum
and rst detected P. vivax parasitaemias
(see Figure) may, however, be attributed
to the suppression of the parasitaemias by
the chloroquine. The overall incidences
recorded in SP2, of 1.1 P. falciparum
infections and 1.5 P. vivax infections/
person-year, are appreciably lower than the
rates — of 2.5–3.3 P. falciparum infections
and 2.3–2.5 P. vivax infections/personyear — measured in other studies in the Arso
area of north–eastern Papua ( Jones et al.,
1994; Ohrt et al., 1997; Taylor et al., 1999).
They are, however, essentially the same as

the rates measured in the nearby settlement
villages of SP4, SP5 and SP6 during 1999
and 2000 (Baird et al., 2001).
Risk of infection may be confounded
by diVerential risk of exposure to biting
anophelines. The degree of this confounding
largely depends upon behaviours that put
mosquitoes in contact with humans. People
who are particularly likely to enter forests,
such as loggers, are more likely to be bitten
by species of anopheline mosquito that ‘prefer’
forest habitats. Children who tend to remain
in the village setting are at relatively low risk
of being bitten by these mosquito species.
In earlier cross-sectional studies of Javanese
migrants to Indonesian Papua, the risk of
parasitaemia and disease appeared to fall for
adults, but not children, after several years
(Baird et al., 1991, 1993). In these studies,
the possibility that the adults were simply at
higher risk of exposure than the children,
because adult-specic behaviours, such as
logging, increased the risk of being bitten by
a potential vector, was discounted. The local
vectors — mosquitoes of the An. punctulatus
complex — avoid forest and prefer the open,
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sun-lit areas to be found in transmigration
villages. It was therefore assumed that transmigrant infection with P. falciparum or
P. vivax occurred predominantly in the
village setting, where children and adults
were at equal risk. Past (Baird et al., 1991,
1993) and present observations (Table 1),
particularly the similar prevalences of parasitaemia and incidences of infection in adult
and child transmigrants during the rst few
months of their exposure, support this view.
In the present study, children and adults
appeared uniformly susceptible to disease
with primary P. falciparum or P. vivax
infection, the associated risks of fever or complaints of illness being essentially identical
for the two age-groups. This observation
appears to conict with that made in an
earlier retrospective analysis of the risks of
severe disease among migrants at Arso PIR
IV (Baird et al., 1998), but essential diVerences in methods almost certainly account
for this discrepancy. In the earlier study in
Arso PIR IV, adults appeared much more
likely to experience severe disease, during
the rst few months of exposure to infection,
than children. This observation, however,
was made in the absence of readily available
diagnosis and treatment. In SP2, subjects
were followed closely and treated at the rst
sign of disease with parasitaemia. In Arso
PIR IV, no active follow-up took place
and residents lacked immediate access to
diagnosis or to medical care provided by a
physician. The availability of these services
in SP2 virtually eliminated the risk of severe
disease (Krisin et al., 2003). Children and
adults appear to be equally susceptible to
mild disease caused by primary exposure to
P. falciparum, even though, in other studies,
adults appeared initially much more likely
than children to experience severe and
complicated disease.
The concept of immunological crossprotection between species of Plasmodium in
humans remains controversial (McKenzie and
Bossert, 1999; Bruce et al., 2000; TaylorRobinson, 2000). Exposure to the antigens
of one species may prime a protective

immune response to infection by another
species. In the present SP2 cohort, however,
the risk of fever or complaint of illness when
rst infected with P. falciparum was similar
whether there had been a prior infection with
P. vivax or not, and vice versa. This was
true among both children and adults. The
SP2 cohort, however, would not allow the
detection of functional cross-protection
from severe disease.
In summary, fever and complaints of illness occurred among most Javanese migrants
to Papua experiencing rst exposure to
P. falciparum or P. vivax. For each Plasmodium
species, neither the host’s age nor prior
exposure to the other species confounded
the risk of fever or illness. The nding of
equal incidences of infection in children and
adults supports the assumption, of similar
exposure to infection across all age-groups,
made in earlier studies on the patterns of
parasitaemia and disease in migrants to
Indonesian Papua.
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